The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...
Editor's Note: This is an excerpt from WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. Bladder cancer hits men especially hard. The ...
Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Doctors at a South Shore animal hospital treated a turtle with a baseball-sized bladder stone on Wednesday.According to a social media post by the New England Wildlife Center, the chelonian had a ...
Sept 10 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's (JNJ.N), opens new tab drug delivery system for a type of bladder cancer, offering a potential surgery-free ...
Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...
Topline results from the IMvigor011 trial show that ctDNA-guided adjuvant atezolizumab improves survival in patients with MIBC. Adjuvant atezolizumab in patients who are ctDNA-positive after radical ...
Do you pee a lot or feel the urge to go when you are feeling anxious or stressed? You are not alone. Research indicates a positive correlation between the severity of anxiety symptoms and overactive ...
Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder cancer population. Tecentriq helped certain patients with muscle-invasive ...
Artificial intelligence startup OpenEvidence says its AI model has scored a perfect 100% on the United States Medical Licensing Examination (USMLE), raising the bar on the proficiency of AI models to ...
Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Tuesday that its antibody-drug conjugate Padcev extended survival when combined with the cancer immunotherapy ...
Patients with urinary incontinence, sudden and overwhelming urges to urinate, frequent urination and similar problems are usually given the traditional urodynamic test to measure how well the bladder ...